IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0238961.html
   My bibliography  Save this article

Two-step multi-omics modelling of drug sensitivity in cancer cell lines to identify driving mechanisms

Author

Listed:
  • Nina Kusch
  • Andreas Schuppert

Abstract

Drug sensitivity prediction models for human cancer cell lines constitute important tools in identifying potential computational biomarkers for responsiveness in a pre-clinical setting. Integrating information derived from a range of heterogeneous data is crucial, but remains non-trivial, as differences in data structures may hinder fitting algorithms from assigning adequate weights to complementary information that is contained in distinct omics data. In order to counteract this effect that tends to lead to just one data type dominating supposedly multi-omics models, we developed a novel tool that enables users to train single-omics models separately in a first step and to integrate them into a multi-omics model in a second step. Extensive ablation studies are performed in order to facilitate an in-depth evaluation of the respective contributions of singular data types and of combinations thereof, effectively identifying redundancies and interdependencies between them. Moreover, the integration of the single-omics models is realized by a range of distinct classification algorithms, thus allowing for a performance comparison. Sets of molecular events and tissue types found to be related to significant shifts in drug sensitivity are returned to facilitate a comprehensive and straightforward analysis of potential computational biomarkers for drug responsiveness. Our two-step approach yields sets of actual multi-omics pan-cancer classification models that are highly predictive for a majority of drugs in the GDSC data base. In the context of targeted drugs with particular modes of action, its predictive performances compare favourably to those of classification models that incorporate multi-omics data in a simple one-step approach. Additionally, case studies demonstrate that it succeeds both in correctly identifying known key biomarkers for sensitivity towards specific drug compounds as well as in providing sets of potential candidates for additional computational biomarkers.

Suggested Citation

  • Nina Kusch & Andreas Schuppert, 2020. "Two-step multi-omics modelling of drug sensitivity in cancer cell lines to identify driving mechanisms," PLOS ONE, Public Library of Science, vol. 15(11), pages 1-22, November.
  • Handle: RePEc:plo:pone00:0238961
    DOI: 10.1371/journal.pone.0238961
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0238961
    Download Restriction: no

    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0238961&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pone.0238961?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Lisa-Katrin Schätzle & Ali Hadizadeh Esfahani & Andreas Schuppert, 2020. "Methodological challenges in translational drug response modeling in cancer: A systematic analysis with FORESEE," PLOS Computational Biology, Public Library of Science, vol. 16(4), pages 1-23, April.
    2. Benjamin Haibe-Kains & Nehme El-Hachem & Nicolai Juul Birkbak & Andrew C. Jin & Andrew H. Beck & Hugo J. W. L. Aerts & John Quackenbush, 2013. "Inconsistency in large pharmacogenomic studies," Nature, Nature, vol. 504(7480), pages 389-393, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Paul Geeleher & Nancy Cox & R Stephanie Huang, 2014. "pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels," PLOS ONE, Public Library of Science, vol. 9(9), pages 1-3, September.
    2. Xiao-Song Wang & Sanghoon Lee & Han Zhang & Gong Tang & Yue Wang, 2022. "An integral genomic signature approach for tailored cancer therapy using genome-wide sequencing data," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    3. Elisabeth Prince & Jennifer Cruickshank & Wail Ba-Alawi & Kelsey Hodgson & Jillian Haight & Chantal Tobin & Andrew Wakeman & Alona Avoulov & Valentina Topolskaia & Mitchell J. Elliott & Alison P. McGu, 2022. "Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    4. Adrià Fernández-Torras & Miquel Duran-Frigola & Martino Bertoni & Martina Locatelli & Patrick Aloy, 2022. "Integrating and formatting biomedical data as pre-calculated knowledge graph embeddings in the Bioteque," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    5. Naiqian Zhang & Haiyun Wang & Yun Fang & Jun Wang & Xiaoqi Zheng & X Shirley Liu, 2015. "Predicting Anticancer Drug Responses Using a Dual-Layer Integrated Cell Line-Drug Network Model," PLOS Computational Biology, Public Library of Science, vol. 11(9), pages 1-18, September.
    6. Jurica Levatić & Marina Salvadores & Francisco Fuster-Tormo & Fran Supek, 2022. "Mutational signatures are markers of drug sensitivity of cancer cells," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    7. Caitlin E. Mills & Kartik Subramanian & Marc Hafner & Mario Niepel & Luca Gerosa & Mirra Chung & Chiara Victor & Benjamin Gaudio & Clarence Yapp & Ajit J. Nirmal & Nicholas Clark & Peter K. Sorger, 2022. "Multiplexed and reproducible high content screening of live and fixed cells using Dye Drop," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    8. David A Knowles & Gina Bouchard & Sylvia Plevritis, 2019. "Sparse discriminative latent characteristics for predicting cancer drug sensitivity from genomic features," PLOS Computational Biology, Public Library of Science, vol. 15(5), pages 1-18, May.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0238961. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.